The US Solicitor General says the US Patent and Trademark Office is wrong to have granted patents on isolated DNA, as the US Court of Appeals for the Federal Circuit hears oral arguments in the Myriad gene patenting case
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.